| Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem … M Barkhordar, A Kasaeian, G Janbabai, H Kamranzadeh Fumani, ... Frontiers in Immunology 13, 921293, 2022 | 19 | 2022 |
| Advances in natural killer cell therapies for breast cancer SZF Kiaei, A Nouralishahi, M Ghasemirad, M Barkhordar, S Ghaffari, ... Immunology and Cell Biology 101 (8), 705-726, 2023 | 16 | 2023 |
| Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to … M Barkhordar, A Kasaeian, G Janbabai, SA Mousavi, HK Fumani, ... Leukemia Research 120, 106918, 2022 | 13 | 2022 |
| Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients M Ahmadvand, MS Barough, M Barkhordar, A Faridfar, A Ghaderi, ... BMC cancer 23 (1), 1090, 2023 | 11 | 2023 |
| Guidance for facing dilemmas of hematopoietic stem cell transplant clinicians in the COVID-19 pandemic: An Iranian Consensus SA Mousavi, S Rad, T Rostami, M Vaezi, HK Fumani, D Babakhani, ... Mediterranean Journal of Hematology and Infectious Diseases 12 (1), e2020050, 2020 | 10 | 2020 |
| Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease‐Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease‐19 M Barkhordar, FT Rostami, M Yaghmaie, M Abbaszadeh, B Chahardouli, ... Case reports in hematology 2022 (1), 2603607, 2022 | 8 | 2022 |
| The impact of malnutrition on mortality and complications of hematopoietic stem cell transplantation in patients with acute leukemia RA Khosroshahi, M Barkhordar, S Talebi, H Imani, E Sadeghi, ... Clinical Nutrition 42 (12), 2520-2527, 2023 | 6 | 2023 |
| Selection of suitable alternative donor in the absence of matched sibling donor: A retrospective single-center study to compare between haploidentical, 10/10 and 9/10 unrelated … M Barkhordar, A Kasaeian, S Tavakoli, M Vaezi, HK Foumani, T Bahri, ... International Journal of Hematology-Oncology and Stem Cell Research 15 (1), 51, 2021 | 6 | 2021 |
| Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a … M Barkhordar, B Chahardouli, A Biglari, M Ahmadvand, T Bahri, ... Frontiers in Immunology 14, 1169666, 2023 | 5 | 2023 |
| Etiologic Causes of Invasive Fungal Sinusitis among Patients of, University Hospitals in Shiraz, Iran H Rouzbahani, P Badiee, M Barkhordar, A Badiee, A Faramarzi, ... Journal of Isfahan Medical School 29 (153), 1286-1296, 2011 | 5 | 2011 |
| Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up M Saleh, AA Vaezi, AA Sohrabpour, M Barkhordar, L Aghaghazvini, ... Gene Reports 29, 101691, 2022 | 4 | 2022 |
| SupplAzithromycin for prevention of graft-versus-host disease: A randomized placebo-controlled trial M Barkhordar, M Mohammadi, M Hadjibabaie, A Ghavamzadeh International Journal of Hematology-Oncology and Stem Cell Research 12 (2), 77, 2018 | 4 | 2018 |
| Promotion of healthy heart knowledge and attitude in elementary school students in Shahrekord, Iran A Rouzbahani, R Rouzbahani, H Rouzbahani, M Barkhordar, ... ARYA Atherosclerosis 5 (2), 2009 | 4 | 2009 |
| Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study M Azari, M Barkhordar, T Bahri, S Rad, H Kamranzadeh Fumani, ... Frontiers in Oncology 14, 1339605, 2024 | 3 | 2024 |
| Comparison of three malnutrition screening tools prior to allogeneic hematopoietic stem-cell transplantation RA Khosroshahi, H Mohammadi, M Barkhordar, S Zeraattalab-Motlagh, ... Frontiers in Nutrition 10, 1233074, 2023 | 3 | 2023 |
| Homologous versus heterologous prime-boost COVID-19 vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial L Sharifi Aliabadi, M Karami, M Barkhordar, SS Hashemi Nazari, ... Frontiers in Immunology 14, 1237916, 2023 | 3 | 2023 |
| Clinical features and risk factors of relapse and mortality in thrombotic thrombocytopenic purpura patients: a seven-year experience ST Shiraji, MR Rostami, HK Foumani, SA Mousavi, M Vaezi, S Rad, ... International Journal of Hematology-Oncology and Stem Cell Research 17 (3), 156, 2023 | 2 | 2023 |
| Comparable outcomes of Pre-versus Post-tyrosine kinase inhibitor era treatment in chronic myeloid leukemia: a Retrospective Cohort Study with Long-Term follow-up S Tavakoli, F Khalaj, A Kasaeian, SA Mousavi, AH Mousavian, F Arabi, ... Cell Transplantation 32, 09636897231163212, 2023 | 2 | 2023 |
| Evaluation of safety and immunogenicity of a recombinant receptor-binding domain (RBD)-tetanus toxoid (TT) conjugated SARS-CoV-2 vaccine (PastoCovac) in recipients of … M Barkhordar, M Ahmadvand, L Sharifi Aliabadi, SS Noorani, ... Vaccines 11 (1), 117, 2023 | 2 | 2023 |
| Outcome improvement following haploidentical stem cell transplantation in patients with high risk leukemia: A comparison of high dose post-transplant cyclophosphamide (PT-CY … K Alimoghaddam, A Ghavamzadeh, M Barkhordar BONE MARROW TRANSPLANTATION 50, S137-S137, 2015 | 2 | 2015 |
mohammadali nazariniashiraz university of medical sciencesAdresse e-mail validée de sums.ac.ir